Repligen | RGEN - Operating Expenses



Repligen reported $176.41M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Agilent USD 1.38B 10M Jul/2025
Align Technology USD 849.42M 1.25M Jun/2025
Bio Techne USD 340.82M 63.35M Jun/2025
BioMarin Pharmaceutical USD 548.52M 27.27M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Bruker USD 785.5M 15.9M Jun/2025
Charles River Laboratories USD 899.8M 9.7M Jun/2025
Danaher USD 5.18B 718M Jun/2025
Dentsply International USD 825M 9M Jun/2025
Exact Sciences USD 813.23M 10.44M Jun/2025
General Electric Aerospace USD 8.92B 931M Jun/2025
Henry Schein USD 5.29B 2.3B Jun/2025
Illumina USD 845M 65M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Mettler Toledo International USD 717.51M 35.71M Jun/2025
Myriad Genetics USD 224.9M 24.7M Mar/2025
Pfizer USD 11.62B 1.58B Jun/2025
Repligen USD 176.41M 13.82M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Standard Biotools USD 45.46M 34.07M Jun/2025
Thermo Fisher Scientific USD 8.94B 291M Jun/2025
Waters USD 583.12M 73.16M Jun/2025
West Pharmaceutical Services USD 612.8M 21.8M Jun/2025